AllianceBernstein L.P. significantly reduced nearly half of its position in Cameco Corporation (NYSE: CCJ, TSE: CCO), the world’s largest publicly traded uranium producer, by 42% during the third quarter, as per the most recent SEC (Securities and Exchange Commission) 13F filings of the firm.
Meanwhile, Cameco has recently reported strong 2025 Q4 earnings and is benefiting from a ‘nuclear renaissance’, which is currently driving retail and sector-specific interest. This offloading move comes at a time when Cameco has been hitting multi-year highs.
Even though it contrasts with Cameco’s robust fundamental performance, this strategic stake cut by the leading global investment management firm with roughly $867 billion in AUM, confirms a tactical shift of strategic harvesting and profit taking or a portfolio rebalancing rather than a loss of faith in the sector.
Financial Breakdown and Market Performance
In the Q4 2025 earnings report of Cameco, the company comfortably cleared Wall Street hurdles, posting an EPS of $0.36. The revenue was also seen beating analyst estimates and increasing by an impressive $418 million. These values highlight the strengthening of the uranium market and Cameco’s potential to tap into higher spot prices and long-term contracting.
AllianceBernstein’s decision to trim its stakes when CCJ was frequently displaying dramatic run-ups, hitting multi-year highs, often triggered automated rebalancing or discretionary selling at major funds to prevent the position from exceeding the internal risk concentration limit. During the quarter, the firm sold 2,544,576 shares, retaining only 0.81% (3,519,094 shares) of Cameco valued at $295,111,000.
While the firm has reduced its exposure, the broader institutional sentiment remains clearly optimistic. The current market sentiment sits at ‘Moderate Buy’. Tier-one firms like Goldman Sachs and RBC updated their outlooks by raising the price target to a range of $130-$160, suggesting a divergence in the institutional sentiment with substantial upside momentum driven by the global nuclear energy renaissance.
The Broader Nuclear Supercycle and Outlook
The pivotal bull run of Cameco stems from a structural deficit. This perfect storm of tight uranium supply is due to the struggle of primary production to meet the spiking global demand. The secondary reserves, with the historic support of down-blended weapon-grade material and underfed enrichment tails, have significantly reduced. Furthermore, the active global shift towards energy security and decarbonization has transformed nuclear power from a sidelined technology into a cornerstone of modern politics and national energy policies.
The key factor of Cameco’s growth is the strategic integration with Westinghouse. This acquisition and the subsequent partnership with the U.S. government positioned Cameco as a major player in the industry, with vertically integrated power. These actions create a valuation floor through diversification by accelerating reactor deployment and providing lifecycle services, thus shielding the company from pure commodity price volatility and fixing it into the infrastructure of the Western energy grid.
This 42% reduction move by the AllianceBernstein is not a signal to sell in the industry, but rather a standard institutional navigation for a diversified portfolio by trimming an overgrown winning position. The underlying nuclear renaissance factor remains strong, with major institutions attempting to lock in their gains, suggesting that the chapters of the uranium market are only beginning to unfold.
